2638
S. M. Mantovani et al. / Tetrahedron: Asymmetry 20 (2009) 2635–2638
oil, 2.4 g (12.87 mmol, 93%). The product was used directly to ob-
tain 4-tert-butyldimethylsilyloxy-1,2-butanediol 9.
NaCl. For substrates ( )-1, ( )-5, and ( )-6, the conversion was
based on residual alcohols in comparison with the internal stan-
dard (benzophenone, 0.1 mg mLÀ1), and the enantiomeric excesses
were determined by GC-FID with a chiral phase. The absolute con-
figurations were obtained by coinjection of racemic 1, 5, and 6 with
the appropriate (S)-enantiomers.
For substrate ( )-3, the conversion was based on residual alco-
hols in comparison with the internal standard (pentadecane,
0.05 mg/mL) and analysis by GC–MS. The enantiomeric excess
was determined by 1H NMR analysis of (S)-methoxyphenylacetic
acid [(S)-MPA] derivatives.18 The assignment of absolute configura-
tion was also made by 1H NMR analysis in comparison with the (S)-
MPA derivative of (S)-3.
Synthesis of 4-tert-butyldimethylsilyloxy-1,2-butanediol 9: Com-
pound 5 (1.2 g, 6.44 mmol) was dihydroxylated following procedure
III. Purification of the crude product by flash chromatography
(hexane/EtOAc, 8:2) afforded 9 as a colorless oil, 1.07 g (4.9 mmol,
76%). 1H NMR (300.06 MHz, CDCl3) d in ppm: 0.00 (s, 3H), 0.08 (s,
3H), 0.90 (s, 9H), 2.19 (s, 2H), 2.62 (s, 2H), 3.59 (m, 1H), 3.86 (m,
2H); 13C NMR (75.45 MHz, CDCl3) d ppm: -5.6 (CH3), -5.5 (CH3),
18.0 (C), 25.8 (CH3), 34.8 (CH2), 61.7 (CH2), 66.6 (CH2), 71.8 (CH);
EI/MS m/z: 189 (11), 145 (57), 133 (14), 115 (15), 105 (24), 89 (20),
75 (100).
Synthesis of 1-benzyloxy-4-tert-butyldimethylsilyloxy-2-butanol
10: Compound 9 (361.6 mg, 1.64 mmol) was protected with benzyl
bromide following procedure I. Purification of the crude product by
flash chromatography (hexane/EtOAc, 6:4) afforded 10 as a color-
less oil, 406.3 mg (1.31 mmol, 80%). 1H NMR (300.06 MHz, CDCl3)
d ppm: 0.07 (s, 3H), 0.09 (s, 3H), 0.90 (s, 9H), 1.70 (q, 2H), 3.50
(m, 1H), 3.81 (m, 2H), 4.09 (p, 2H), 4.51 (s, 2H), 7.37 (m, 5H); 13C
NMR (75.45 MHz, CDCl3) d ppm: À5.39 (CH3), À5.4 (CH3), 18.3
(C), 25.9 (CH3), 67.0 (CH2), 67.9 (CH2), 70.4 (CH), 73.2 (CH2),
127.6 (CH), 128.4 (CH), 129.6 (CH), 138.2 (C); EI/MS m/z: 310 (1),
203 (1), 179 (1), 161 (9), 131 (3), 91 (100), 75 (10).
Acknowledgments
The authors are grateful for the financial support from PETRO-
BRAS, Conselho Nacional de Desenvolvimento Científico e Tec-
nológico (CNPq) and the Coordenação de Aperfeiçoamento de
Pessoal de Nível Superior (Capes). We also thank Prof. Carol Collins
for helpful suggestions in style and grammar.
Synthesis of ( )-1-benzyloxy-2,4-butanediol 4: Compound 10
(128 mg, 0.41 mmol) was deprotected with an acidic resin (Dowex
50Wx8) quantitatively in the presence of methanol. Filtration and
evaporation of the crude product afforded 4 as a colorless oil. 1H
NMR (300.06 MHz, CDCl3) d in ppm: 1.70 (m, 2H), 3.53 (m, 2H),
3.87 (t, 2H), 4.12 (m, 1H), 4.56 (s, 2H), 7.43 (m, 5H); 13C NMR
(75.45 MHz, CDCl3) d in ppm: 35.0 (CH2), 61.9 (CH2), 71.2 (CH),
73.0 (CH2), 74.6 (CH2), 128.0 (CH), 128.5 (CH), 129.0 (CH), 138.2
(C); EI/MS m/z: 196 (1), 151 (1), 121 (5), 107 (27), 105 (5), 91
(100), 89 (3), 75 (20).
References
1. Utsukira, T.; Misumi, O.; Nakajima, K.; Koshimura, M.; Kuniyoshi, M.; Kuroiwa,
T.; Akira Horiuchi, C. J. Mol. Catal. B: Enzym. 2008, 51, 19–23.
2. (a) Gladiali, S.; Alberico, E. Chem. Soc. Rev. 2006, 35, 226–236; (b) Samec, J. S.
M.; Backvall, J. E.; Andersson, P. G.; Brandt, P. G. Chem. Soc. Rev. 2006, 35, 237–
248.
3. Bonascheuer, U. T.; Bessler, C.; Srinivas, R.; Krishna, S. H. Trends Biotechnol.
2002, 20, 433–437.
4. Vaijayanthi, T.; Cadha, A. Tetrahedron: Asymmetry 2007, 18, 1077–1084.
5. (a) Voss, C. V.; Gruber, C. C.; Kroutil, W. Angew. Chem., Int. Ed. 2008, 47, 741–
745; (b) Nie, Y.; Xu, Y.; Mu, X. Q.; Tang, Y.; Jiang, J.; Sun, Z. H. Biotechnol. Lett.
2005, 27, 23–26; (c) Lu, Y.; Xu, Y.; Mu, X.; Nie, Y. Chin. J. Catal. 2007, 28, 446–
450.
4.4. Cell free assay
6. Baskar, B.; Pandian, N. G.; Priya, K.; Cadha, A. Tetrahedron 2005, 61, 12296–
12306.
The oxidoreduction reactions were investigated in a miniatur-
7. (a) Padhi, S. K.; Pandian, N. G.; Chadha, A. J. Mol. Catal. B: Enzym. 2004, 29, 25–
29; (b) Padhi, S. K.; Chadha, A. Tetrahedron: Asymmetry 2005, 16, 2790–2798;
(c) Padhi, S. K.; Titu, D.; Pandian, N. G.; Cadha, A. Tetrahedron 2006, 62, 5133–
5140.
8. (a) Cardus, G. J.; Carnell, A. J.; Trauthwein, H.; Riermeir, T. Tetrahedron:
Asymmetry 2004, 15, 239–243; (b) Comasseto, J. V.; Andrade, L. H.; Omori, A. T.;
Assis, L. F.; Porto, A. L. M. J. Mol. Catal. B: Enzym. 2004, 29, 55–61; (c) Nakamura,
K.; Fujii, M.; Ida, Y. Tetrahedron: Asymmetry 2001, 12, 3147–3153.
9. Allan, G. R.; Carnell, A. J. J. Org. Chem. 2001, 66, 6495–6497.
10. Hasegawa, J.; Ogura, M.; Tsuda, S.; Maemoto, S.; Kutsuki, H.; Ohashi, T. Agric.
Biol. Chem. 1990, 54, 1819–1828.
ized format using 200
reactions were carried out in phosphate buffer pH 7.0 containing
the substrate ( )-1 (10 L,
L, 2.0 mmol LÀ1), NAD+ or NADP+ (80
7.5 mmol LÀ1) and after 2 min of incubation at 25 °C, the free cell
extracts (100 L) were added and the absorbance was monitored
at 304 nm during 24 h. For GC–MS analysis the reaction (500 L)
lL 96-well microtiter plates. The oxidation
l
l
l
l
was extracted with ethyl acetate containing benzophenone
(0.01 mg mLÀ1) as an internal standard. Same procedure was ap-
11. (a) Stecher, H.; Faber, K. Synthesis 1996, 1–16; (b) Strauss, U. T.; Felfer, U.;
Faber, K. Tetrahedron: Asymmetry 1999, 10, 107–117.
12. Xie, S.-X.; Ogawa, J.; Shimizu, S. Biosci. Biotechnol. Biochem. 1999, 63, 1721–
1729.
plied to 2 (10 l lL,
L, 2.0 mmol LÀ1) and NADH or NADPH (80
7.5 mmol LÀ1).
13. Nie, Y.; Xu, Y.; Mu, X. Q. Org. Proc. Res. Dev. 2004, 8, 246–251.
14. Chen, L. S.; Mantovani, S. M.; de Oliveira, L. G.; Duarte, M. C. T.; Marsaioli, A. J. J.
Mol. Catal. B: Enzym. 2008, 54, 50–54.
4.5. General procedure for the biotransformation reaction
15. Gruber, C. C.; Lavandera, I.; Faber, K.; Kroutil, W. Adv. Synth. Catal. 2006, 348,
1789–1805.
16. Azerad, R.; Buisson, D. Curr. Opin. Biotechnol. 2000, 11, 565–571.
17. Voss, C.; Gruber, C. C.; Faber, K.; Knaus, T.; Macheroux, P.; Kroutil, W. J. Am.
Chem. Soc. 2008, 130, 13969–13972.
Whole cells (2–4 g) were stirred in a 125-mL Erlenmeyer flask
at 150 rpm containing 40 mL of phosphate buffer, pH 7.0, and
maintained at 28 °C. Then, 20
to the medium (final substrate concentration 1
l
L of the racemic diol were added
l
L mLÀ1). The bio-
18. Trost, B. M.; Belletire, J. L.; Godlesk, S.; McDougal, P. G.; Balkovec, J. M. J. Org.
Chem. 1986, 51, 2370–2374.
conversion was monitored from time to time by extracting aliquots
from the bioreaction with organic solvent after saturation with